Skip to content
Corporate Presentation
Date Documents PDF Download
November 5, 2024 Karyopharm 3Q24 Earnings Presentation
October 31, 2024 Karyopharm Therapeutics Phase 3 Sentry Trial Update

 

Karyopharm Therapeutics Endometrial Cancer KOL Event at 2024 ASCO Annual Meeting
 Saturday, June 1, 2024
 4:30pm EDT
3.3 MB
I agree to the storing and processing of my personal data by Karyopharm as described in the Privacy Policy and to the Terms of Use . I agree to receive communications from Karyopharm and understand that I can unsubscribe at any time.